RL-007 was well tolerated and demonstrated a clinically meaningful pro-cognitive profile Changes in quantitative electroencephalogram (qEEG) were consistent with the results of a previous Phase 1 trial
Investegate announcements from atai Life Sciences, atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia
With Type 1 Diabetes, Cognition Declines With Aging, Lack of Control of Glycemia and BP psychiatryadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychiatryadvisor.com Daily Mail and Mail on Sunday newspapers.